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Abstract  
Background: Despite treating patients with in vitro effective antibiotics, Staphylococcus aureus 
infections often relapse because they hide in privileged locations such as abscesses or host 
cells. Both, abscesses and host cells, feature compartments characterized by low pH and from 
both non-stable S. aureus small colony variants (SCVs) are frequently recovered.  
Methods: We assessed the effect of low pH on S. aureus colony phenotype and bacterial 
growth, using in vitro and in vivo long-term infection models. 
Results: We showed that low pH induced non-stable SCVs and non-replicating persisters, 
capable of regrowth. Within host cells, S. aureus was located in phagolysosomes, a low pH 
compartment. Therapeutic neutralization of phagolysosomal pH with ammonium chloride, 
bafilomycin A1, or the anti-malaria-drug chloroquine reduced SCVs in infected host cells. In a 
systemic mouse infection model, treatment with chloroquine also reduced SCVs.  
Conclusions: Our results show that the acidic environment favors formation of non-stable 
SCVs, reflecting SCVs found in clinics. They also provide evidence that alkalinizing agents 
together with antibiotics may provide a novel translational strategy for eradicating intracellular 
persisting staphylococcal reservoirs. This approach may also be extended to other intracellular 
bacteria. 
 
 at U
niversitaet Zuerich on D
ecem
ber 17, 2015
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
Ac
ce
pte
d M
an
us
cri
pt
4 
Introduction 
The human pathogen Staphylococcus aureus colonizes approximately a third of all humans and 
is one of the leading causes of bacteremia and infective endocarditis in the industrialized world 
[1]. In addition to emerging antibiotic resistance, persisting and recurrent infections substantially 
add to morbidity and mortality [2, 3]. Recurrence rates, in particular after osteomyelitis or 
endocarditis, are high and infections may relapse even years after apparent cure [4]. 
Infection recurrence is associated with non-stable SCVs and/or non-replicating persisters for 
several reasons [5-8]. Their arrested or slow growth and reduced metabolism renders antibiotics 
inefficient [9-13]. Moreover, they preferentially hide in privileged locations such as in abscesses 
and within host cells [14-17]. These privileged locations shield them from the host’s innate 
immune system and from extracellularly active antibiotics. In addition, antibiotics do not 
penetrate abscesses efficiently and are less active due to the low pH [18-22]. Therefore the ‘ubi 
pus ibi evacua’ – the necessity of surgical removal of abscesses formulated in the antiquity still 
applies nowadays despite highly active antibiotics. In contrast to abscesses, intracellular 
bacteria cannot be mechanically removed and often resist eradication by currently available 
antibiotics.  
Most SCVs isolated in clinical microbiology laboratories revert to the large colony phenotype 
upon sub-cultivation. Due to these non-stable properties, stable genetically-modified SCV 
mutants with defects in the electron transport system have been used to find new strategies to 
target SCVs and have been found to localize in host cell lysosomes [23]. However, stable SCVs 
only partially reflect the clinical SCVs. They are less virulent [24] and do not revert.   
Due to the non-stable characteristics, clinical SCVs have not been studied so far in detail. It 
remains unclear how SCVs are induced and maintained in patients. We established conditions 
mimicking the host environment in which non-stable non-replicating persisters and/or SCVs are 
found. Low pH induced reversible persisters and/or SCVs. Low pH adapted bacteria persisted 
within lysosomes by cessation of growth resulting in SCVs on agar plates. In contrast to the 
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stable genetically modified SCVs used so far, low pH-induced non-stable SCVs reverted to the 
highly virulent and fast-growing form, reflecting SCVs isolated in clinics which are most likely 
responsible for causing recurrent infections. Staphylococcal SCVs and/or intracellular persisters 
were reduced in vivo as well as in vitro by combination therapy consisting of phagolysosome 
alkalinization plus antibiotics. These findings indicate generally applicable novel therapeutic 
strategies against intracellularly persisting S. aureus. 
 
Materials and Methods 
Cell lines, bacterial strains and culture conditions 
The human lung epithelial carcinoma cell line A549 [25] was purchased from ATCC (ATCC CCL-
185). The cells were maintained in our laboratory and grown in Dulbecco’s Modified Eagle 
Medium (DMEM, Life Technologies) supplemented with 10% FBS (Fetal Bovine Serum, GE 
Healthcare) at 37 °C in 5 % CO2. 
The Staphylococcus aureus strains used in this study are listed in Table 1. S. aureus was grown 
in LB Lennox broth (BD Biosciences) at 37 °C, shaking or on Columbia agar + 5 % sheep blood 
plates (BioMérieux). 
Media with adjusted pH (pH 4.0, 5.5, 6.5 and 7.4) were prepared with DMEM (4.5 g/ml Glucose, 
without Phenolred, Pyruvat and L-Glutamine, Life Technologies) supplemented with 10 % FBS 
and 4 mM of L-Glutamine (Life Technologies). The pH 4.0, 5.5 and 6.5 media were prepared 
with buffers (containing Na2HPO4 and citric acid, both from Fluka) of pH 2.6, 4.0 and 5.6, 
respectively and were mixed at a ratio of 3:7 with DMEM. pH 7.4 was maintained by 50 mM 
HEPES (Life Technologies).  
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pH dependent SCVs induction assay 
S. aureus colonies were picked and used to inoculate the defined pH media (pH 4.0, 5.5, 6.5 
and 7.4) to a starting optical density of 0.2 at 600nm (OD600) and further incubated without 
shaking at 37 °C in 5 % CO2 for up to 7 days. The pH and the OD600 of cultures were measured 
daily. To enumerate viable bacteria, culture aliquots were removed, serial-fold diluted and plated 
on blood agar plates.  
Colony forming units (CFUs) were enumerated after overnight incubation at 37 °C. The colony 
phenotype was determined by morphological analysis after an additional overnight incubation at 
room temperature. Small colony variants (SCVs) were identified based on their size (one tenth 
the size of normal colonies), reduced pigmentation and reduced hemolysis.  
To detect non-replicating persisters, bacteria were stained with DsRed-tagged S. aureus cell 
wall binding domains (CBDs). CBDs bind to the bacterial cell wall with high affinity and allow the 
tracking of peptidoglycan synthesis and bacterial replication [26]. In brief, bacteria were mixed 
with 0.1 mg/ml DsRed-CBDs in PBS (50 mM NaH2PO4, 120 mM NaCl, pH 6), washed and 
added to the defined pH media for further cultivation. Before visualization, cultures were washed 
and resuspended in PBS pH 8.0.   
Intracellular persistence model 
A549 cells (1 x 106) were seeded into the wells of a 12 well plate in 1 ml medium.  Cells were 
infected as described previously with minor modifications [14]. Briefly, cells were infected with S. 
aureus Cowan at a multiplicity of infection (MOI) of 1 or 100 for intracellular persistence assays 
and microscopy, respectively. Three hours post-infection, cells were washed with Dulbecco’s 
Phosphate Buffered Saline (DPBS, Life Technologies) and Flucloxacillin (Actavis, 1 mg/ml in 
DMEM + 10 % FBS) was added in DMEM for 2 hours to kill any extracellular bacteria. 
Supernatants were monitored for sterility by plating an aliquot on agar plates. Flucloxacillin-
containing media were supplemented with lysosomotropic alkalinizing agents (20 µM 
chloroquine, 1 nM bafilomycin A1, 5 mM ammonium chloride, all from Sigma). Flucloxacillin-
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containing media without lysosomotropic alkalinizing agents served as controls. The washing 
step was repeated and fresh medium was added to the cells daily.  
After extensive washing with DPBS, host cells were lysed (0.08 % Triton X-100 from Fluka in 
DPBS) and serial-fold dilutions of the cell lysates were plated onto blood agar plates to detect 
intracellular persisting bacteria. CFUs were enumerated and the colony phenotype determined.  
To assess cell damage induced by S. aureus or by lysosomotropic alkalinizing agents, 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays were performed as 
previously described [27]. Non-infected, non-treated cells served as 100 % cell viability control. 
Fluorescence staining and confocal microscopy  
Bacteria were labeled with Carboxy-Fluorescein diacetate Succinimidyl Ester (CFSE, Life 
Technologies) prior to host cell infection according to manufacturer’s instructions. Infected cells 
were fixed with 4 % paraformaldehyde (EMS), permeabilized with 0.2 % Triton X-100 and 
blocked with 2 % bovine serum albumin (Sigma). Lysosomes were visualized with mouse anti-
human LAMP2-CD107b primary antibody (BD Biosciences) and with Alexa Fluor 594-conjugated 
goat anti-mouse IgG secondary antibody (Life Technologies). Purified Mouse IgG1 κ was used 
as isotype control (BD Biosciences). DNA was stained with 4’,6-Diamidin-2-phenylindol (DAPI, 
Sigma). Samples were visualized at room temperature by confocal microscopy (CLSM SP5, 
Leica) and a 63x objective (HCX PL APO lambda blue 63.0x1.40 OIL UV) using Leica LAS AF 
software. Images were processed using Imaris (version 7.1.1), and Photoshop (Adobe). 
Deconvolution was done with Huygens software (SVI).  
To assess the pH of phagolysosomes, A549 cells treated with flucloxacillin only or supplemented 
with lysosomotropic alkalinizing agents were stained with 5 µg/ml acridine orange (Sigma) for 
15min and analyzed by confocal microscopy [28]. 
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Scanning Electron Microscopy 
Bacteria grown on agar plates or in liquid media were fixed with 2.5 % glutaraldehyde in DPBS 
and harvested onto glass slides using a cytospin (3 min, 1000 rpm). After incubation in 1 % 
osmium tetroxide, bacteria were dehydrated with an increasing concentration of ethanol (70-
100%), critical-point dried (Bal Tec CPD 030, Leica) and coated with 5 nm of platinum in a 
sputtering device (Bal Tec SCD 500, Leica). The samples were examined with a field emission 
scanning electron microscope (SUPRA 50 VP, Zeiss) using the in-lens detector. 
Transmission Electron Microscopy 
Infected A549 cells were fixed with 2.5% glutaraldehyde and 1% formaldehyde in DPBS. After 
incubation in 1 % osmium tetroxide and staining with 1% uranyl acetate, cells were embedded in 
resin. Ultrathin sections (70 nm in thickness) were prepared using an ultramicrotome (Ultracut E, 
Reichert), collected on slot copper grids and stained with Reynolds lead citrate. The sections 
were examined using a Philips CM100 transmission electron microscope equipped with a side 
mounted digital camera (4k x 3k, Gatan). 
Ethics Statement 
Mice were purchased from Janvier, France, and handled in accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the National 
Institutes of Health. The protocol 140/2011 was approved by the Institutional Animal Care and 
Use Committee of the University of Zurich.  All efforts were made to minimize suffering of 
animals employed in this study. 
Mouse infection model 
C57BL/6 wild-type mice (8-11 weeks old) were infected intraperitoneally (ip) with S. aureus 
Cowan (108 CFUs). Eight hours post-infection, mice were treated once with flucloxacillin (1 mg 
ip) alone or with chloroquine (0.2 mg ip [29]) in addition. Chloroquine (0.2 mg ip) was redosed 
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after 48 hours. Three days post-infection, mice were euthanized and organs were harvested for 
bacterial counts. 
 
Results  
pH-dependent induction of S. aureus Small Colony Variants (SCVs) 
The well-defined MSSA strains 6850 and Cowan and MRSA strain JE2 were grown in 4.0, 5.5, 
6.5 and 7.4 pH media, mimicking the pH found in physiologic sites such as lysosomes, 
abscesses and blood. Directly after inoculation S. aureus showed a large colony phenotype, 
independent of the pH. The frequency of SCVs significantly increased over time in pH 4.0 growth 
medium and reached 39% (JE2 and 6850) and 28% (Cowan) after five days (Figure 1A). In 
contrast, pH 7.4 growth medium sustained SCVs below 2% in all strains tested (Figure 1A). An 
intermediate percentage of SCVs was found at pH 5.5 and 6.5. (Total colony counts and 
absolute SCV numbers are shown in Supplementary Figure 1). Thus, we showed a clear 
correlation between low pH and non-stable SCV formation. This method permitted easy and 
controlled formation of non-stable, non-genetically modified SCVs in various S. aureus strains.  
Induction of non-replicating S. aureus by low pH  
The pH-dependent growth of S. aureus Cowan was followed over time by labeling the bacterial 
cell wall with fluorescent cell wall binding domains (CBDs) [26, 30]. Immediately after staining, 
bacterial cell walls were fully labeled (control, Figure 1B I). After three days in pH 4.0 growth 
medium, the majority of bacteria still exhibited fluorescent cell walls, consistent with absent 
bacterial replication (Figure 1B II). In contrast, bacteria grown at pH 7.4 proliferated extensively, 
demonstrated by highly fragmented and reduced fluorescent cell wall labeling (Figure 1B III).  
Scanning electron microscopy (SEM) of bacteria originating from a small colony (Figure 1C), 
obtained under low-pH conditions, showed impaired cell division resulting in rod-shaped S. 
aureus, in contrast to large colony bacteria showing normal cell division (Figure 1C, arrows).  
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Growth resumption of low pH-adapted S. aureus persisters 
Our findings indicated that both, SCVs and non-replicating persisters, are induced by low pH. In 
clinical practice, the presence of these persisting bacteria correlate with increased recurrence of 
infection which implies that bacteria revert to a highly virulent and fast-growing form [14]. We 
therefore tested in vitro whether low pH-induced SCVs and/or non-replicating persisters can 
restore normal growth in neutral pH. Non-replicating S. aureus persisters were induced and kept 
at pH 4.0 for three days and then transferred to pH 4.0, 5.5, 6.5 or 7.4 growth media. Bacteria in 
pH 7.4 and 6.5 resumed growth after approximately 12 hours (Figure 1D) whereas bacteria kept 
at low pHs (< 6.5) remained in a non-proliferating state (Figure 1D). The bacteria transferred to 
pH 7.4 growth medium had a large colony phenotype after eleven hours (Supplementary 
Figures 2A-C). These data suggest that both persisting phenotypes were reversible adaptions 
to low pH as supported by the capability of regrowth and phenotype switch to the fast-growing 
form upon neutralization of pH.  
Intracellular induction of S. aureus SCVs 
We investigated whether internalized S. aureus exhibited a SCV phenotype. MSSA strain 
Cowan is highly invasive, but not cytotoxic [31] which allowed maintaining this strain 
intracellularly over several days in the lung epithelial cell line A549 [27]. Extracellular bacteria 
were killed by adding a high dose of flucloxacillin to the infected host cells. Flucloxacillin is 
typically used to treat S. aureus endocarditis in patients. Absence of extracellular bacteria was 
confirmed by sterility of culture supernatants. Host cells were lysed to release intracellular 
bacteria and colony counts, as well as colony phenotypes, were determined at various time 
points. Five hours after infection, 0.2% of all viable intracellular bacteria had a SCV phenotype 
(Figure 2A). The number of viable intracellular persisting bacteria decreased during the course 
of infection while the frequency of SCVs increased and reached 5.6% after seven days (for 
absolute SCV numbers see Supplementary Figure 3).  
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Phagolysosomal localization of persisting S. aureus  
Our data indicated that acidity favored SCV formation, suggesting that the acidic 
phagolysosomal milieu may have the same effect. A549 cells were infected with S. aureus 
Cowan. Intracellular bacteria were localized within LAMP-2 antibody positive vesicles (Figure 
2B), visualized by fluorescence microscopy. LAMP-2 (CD 107b) is highly expressed in 
phagolysosomes, suggesting that intracellular persisting S. aureus predominantly resided within 
phagolysosomes. Samples stained with IgG1 κ isotype control were negative.  
Reduction of S. aureus SCVs through phagolysosomal alkalinization 
Since low pH induced SCVs and/or non-replicating S. aureus and medium pH neutralization 
resulted in bacterial regrowth, we treated infected host cells with lysosomotropic alkalinizing 
agents. Chloroquine, bafilomycin A1 or ammonium chloride all neutralized the phagolysosomal 
pH (see Supplementary Figures 4A-D). Host cells treated with flucloxacillin plus 
lysosomotropic alkalinizing agents exhibited significantly lower percentages of SCVs seven days 
after infection (Figure 3A). No differences in total colony counts between flucloxacillin and 
flucloxacillin plus alkalinizing agents treated cells were observed (see Supplementary Figure 
5A). Lysosomotropic alkalinizing agents did not inhibit bacterial growth at the concentrations 
used (the minimal inhibitory concentrations of chloroquine, bafilomycin A1 and ammonium 
chloride were above 15.534 mM, 1 µM and 200 mM, respectively, for S. aureus Cowan). 
Absolute SCV numbers are shown in Supplementary Figure 5B. No significant differences in 
host cell viability were observed after treatment with the alkalinizing agents (see Supplementary 
Figure 6).  
Growth resumption and reduction of SCV percentages by chloroquine in cells and in mice 
Growth resumption of S. aureus persisters through treatment of host cells with chloroquine was 
assessed. Fluorescence microscopy revealed that S. aureus localized within phagolysosomes in 
both, flucloxacillin and flucloxacillin plus chloroquine-treated host cells, three days post-infection 
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(see Supplementary Figure 7). We observed no dividing bacteria in infected host cells without 
chloroquine treatment. However, chloroquine facilitated bacterial cell division (Figure 3B) as 
assessed by transmission electron microscopy (TEM).  
Mice infected with S. aureus Cowan were treated with flucloxacillin alone, or with flucloxacillin 
plus chloroquine (Figure 4A). Chloroquine treatment significantly reduced the frequency of 
SCVs in mice in various organs (Figure 4B) and compartments (Figure 4C). Absolute bacterial 
numbers were comparable, independent of chloroquine treatment (see Supplementary Figure 
8A). For absolute SCV numbers see Supplementary Figure 8B. 
 
Discussion  
This study showed that low pH, as found in abscesses and within lysosomes, induced the 
persisting S. aureus subpopulations SCVs and non-replicating persisters. Raising pH in the 
culture medium or within the phagolysosomes using alkalinizing agents reverted S. aureus to 
normal growth.  
SCV formation was shown to be triggered by antibiotic pressure [32]. In addition, extreme 
environmental stresses such as prolonged exposure to low temperature, very acidic or alkaline 
environments, or osmotic stress may trigger SCV and/or persister formation in S. aureus and 
coagulase-negative staphylococci [33]. These observations, together with our new findings, 
show how multiple stimuli lead to S. aureus persister formation. Localization within the host cell 
shields S. aureus from commonly used antibiotics such as the extracellularly active beta-lactams 
with poor cell penetration [34]. In addition, the low intraphagolysosomal pH renders antibiotics 
with intracellular activity such as clindamycin and fluoroquinolones less active [20, 35]. We found 
that the addition of lysosomotropic alkalinizing agents to the usually prescribed antibiotics such 
as flucloxacillin reduced the frequency of S. aureus SCVs in vitro as well as in vivo. We thus 
identified a simple strategy to circumvent the host-dependent component of S. aureus persister 
formation. In clinical settings, the presence of SCVs in osteomyelitis and device-related 
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infections has been associated with increased relapse rates, despite administration of antibiotics 
[5, 35, 36]. Bacteria adapt to antibiotic stress by SCV and/or persister formation [32]. We now 
showed that S. aureus SCVs and non-replicating persisters retained the ability to revert to a 
highly virulent and fast-growing form. The capacity to revert to fast growth (phenotype switching) 
results in relapsing infection. In addition, it renders identification of SCVs difficult. Further 
aggravating the SCV problem is the underestimation of SCVs in clinical microbiology 
laboratories, since they form tiny and thus difficult to detect colonies which are easily overgrown 
by their fast growing counterparts [37].  
We postulate that the addition of alkalinizing agents to the usually prescribed antibiotics will 
reduce the frequency of SCVs and could therefore reduce recurrence rates in the future. 
Chloroquine should also be considered in combination with vancomycin, a drug that has been 
shown to have reduced activity against SCVs [38]. This could, at least in part, explain the high 
relapse rates associated with vancomycin [39]. However, this strategy cannot eradicate 
extracellularly persisting bacteria as found in abscesses or biofilms as chloroquine acts 
specifically on lysosomes. Surgery and antibiotics will remain the treatment of choice for these. 
Even though we show a clear correlation between low pH and non-stable SCV formation, the 
underlying mechanism remains to be elucidated. Whether low pH acts as a trigger and induces 
the formation of new SCVs or whether low pH rather acts as a selective pressure and enriches 
preexisting SCVs is unclear. Yet, the therapeutic strategy of phagolysosomal alkalinization 
employed acts on SCVs in general, i.e. on the preexisting SCVs, as well as on newly formed 
SCVs.  
Persisting bacteria are not unique to S. aureus but have also been described to occur in various 
other human pathogens, such as Salmonella spp., Pseudomonas aeruginosa, Escherichia coli 
and Mycobacterium tuberculosis [5, 40-42]. In addition to low pH, bacterial persisters can arise 
due to mechanisms that include the toxin-antitoxin systems [43, 44]. Accordingly, activation of a 
SOS response (ppGpp) in response to DNA damage due to oxidative stress results in decreased 
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ATP levels [45, 46]. This leads to the shutdown of metabolism resulting in reduced growth. 
Various toxin-antitoxin modules are activated by acidification and/or nutrient starvation in 
Salmonella, causing formation of persisters [47]. In accordance with our findings, Salmonella 
persister formation has been reported in macrophages triggered by the acidic and nutritionally 
poor environment of the Salmonella-containing vacuole that was reversible by addition of 
bafilomycin A1 [47]. In contrast to bafilomycin A1, chloroquine is routinely used in patients to 
treat malaria as well as some rheumatic diseases. Phagolysosomal pH neutralization with 
chloroquine may therefore provide a novel therapeutic eradication strategy against intracellular 
persisting staphylococcal reservoirs. Already, phagolysosomal alkalinization by chloroquine has 
proven to be an effective strategy for eradicating the obligate intracellular bacterium Coxiella 
burnetii, the pathogen responsible for Q fever [48]. Phagolysosomal alkalinization restored the 
activity of intracellular antibiotics resulting in Coxiella burnetii clearance. It is tempting to propose 
that our findings may be applicable to other intracellularly persisting bacterial infections. 
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Figure Legends 
Figure 1. Induction of S. aureus SCVs and non-replicating persisters by low pH and 
bacterial regrowth through pH increase. (A) S. aureus strains 6850, JE2 and Cowan were 
inoculated in media buffered at different pH as indicated. Colony phenotypes of viable bacteria 
were determined and the percentage of SCVs plotted over time. Three independent experiments 
done in triplicates are presented as mean ± SEM. (B) DsRed-CBDs labeled S. aureus Cowan 
was visualized immediately after staining (Control, I) and three days after inoculation in pH 4.0 
(II) and pH 7.4 (III) medium. Respective differential interference contrast (DIC) microscopy 
images. Scale bars 5 µm. (C) Colony phenotype of S. aureus Cowan small- (arrow) and large-
colony variants. Scale bar 1 mm. SEM analysis of bacteria originating from a small- and large-
colony, respectively. Scale bars 1 µm, arrows indicate incomplete bacterial cell division. (D) Low 
pH-induced S. aureus persisters were re-inoculated in various buffered pH media as indicated 
and growth was followed over time. Three independent experiments done in triplicates 
presented as mean ± SEM. 
 
Figure 2. Intracellular persistence of S. aureus within phagolysosomes. A549 cells were 
infected with S. aureus Cowan and extracellular bacteria were killed by addition of flucloxacillin 
[1 mg/ml]. (A) The number and phenotype of viable intracellular persisting bacteria were 
determined at indicated time points. Data are pooled from two experiments performed in 
triplicates, mean ± SEM. (B) The intracellular localization of persisting bacteria (CFSE, green) 
was analyzed by fluorescence microscopy. Lysosomes were visualized with LAMP-2 antibody 
(Alexa Fluor 594, red) and nuclei were stained with DAPI (blue). Scale bars 20 µm and 5 µm, 
respectively.  
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Figure 3. Reduction of S. aureus persisters through phagolysosome alkalinization and 
bacterial cell division after chloroquine treatment. S. aureus Cowan-infected A549 cells 
were treated with flucloxacillin alone (F) or with flucloxacillin plus lysosomotropic alkalinizing 
agents (CQ, chloroquine; Baf A1, bafilomycin A1; and AC, ammonium chloride). (A) Colony 
phenotypes of viable intracellular persisting bacteria were determined and enumerated at 
indicated time points. Data were pooled from three independent experiments done in triplicates, 
mean ± SEM. Two-way ANOVA found the factors time and treatment to be significant (p-value < 
0.01). (B) Visualization of flucloxacillin (F)  and flucloxacillin plus chloroquine (F + CQ) treated 
cells three days post-infection by TEM. Arrows indicate bacterial cell division. All scale bars 2 
µm. 
 
Figure 4. Reduction of S. aureus persisters by chloroquine in an in vivo infection model. 
(A) Mice were infected with S. aureus Cowan intraperitoneally. Six hours and two days post-
infection mice were treated with 1 mg flucloxacillin (F) or with 1 mg flucloxacillin  plus 0.2 mg 
chloroquine (F + CQ). †, sacrifice. Colony phenotypes of bacteria recovered from target tissues 
(B), peripheral blood and peritoneal lavage (C) were determined and enumerated. Each point 
represents one mouse. Horizontal bars indicate mean ± SEM, n = 11 mice per group. PL, 
peritoneal lavage. Two-way ANOVA found the factor treatment to be significant (p-value < 0.01). 
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Table 1. S. aureus strains used in this study 
Strain Properties Reference or source 
6850 
MSSA, WT isolate from osteomyelitis, 
strongly invasive, highly cytotoxic 
ATCC 53657 [49] 
   
JE2 CA-MRSA USA300, WT NARSA1 
   
Cowan I 
MSSA, WT isolate from septic arthritis, 
strongly invasive, reduced cytotoxicity 
ATCC 12598 [50] 
1NARSA, Network of Antimicrobial Resistance in Staphylococcus aureus.  
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